Elaine T Lam (Elaine Lam)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Hyaluronic Acid

Renal Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research communications

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Corbin J Eule, Junxiao Hu, Dale Hedges, Alkesh Jani, Thomas Pshak, Brandon J Manley, Alejandro Sanchez, Robert Dreicer, Zin W Myint, Yousef Zakharia, Elaine T Lam
Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database. Cancers 16 (10) (2024)
Corbin J Eule, Junxiao Hu, Dale Hedges, Alkesh Jani, Thomas Pshak, Brandon J Manley, Alejandro Sanchez, Robert Dreicer, Zin W Myint, Yousef Zakharia, Elaine T Lam
Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database. Cancers 16 (10) (2024)
S Lindsey Davis, Wells A Messersmith, W Thomas Purcell, Elaine T Lam, Bradley R Corr, Alexis D Leal, Christopher H Lieu, Cindy L O'Bryant, Stephen G Smoots, Evan D Dus, Kimberly R Jordan, Natalie J Serkova, Todd M Pitts, Jennifer R Diamond
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors. Cancers 16 (8) (2024)
S Lindsey Davis, Wells A Messersmith, W Thomas Purcell, Elaine T Lam, Bradley R Corr, Alexis D Leal, Christopher H Lieu, Cindy L O'Bryant, Stephen G Smoots, Evan D Dus, Kimberly R Jordan, Natalie J Serkova, Todd M Pitts, Jennifer R Diamond
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors. Cancers 16 (8) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin J Eule, Geetika Srivastava, Douglas J Kemme, Praveena Iruku, Vishal Rana, James Moore, Steven R Schuster, Mali Amirault, Thomas W Flaig, Elaine T Lam
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer research communications 3 (6) (2023)
Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin J Eule, Geetika Srivastava, Douglas J Kemme, Praveena Iruku, Vishal Rana, James Moore, Steven R Schuster, Mali Amirault, Thomas W Flaig, Elaine T Lam
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer research communications 3 (6) (2023)
Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin J Eule, Geetika Srivastava, Douglas J Kemme, Praveena Iruku, Vishal Rana, James Moore, Steven R Schuster, Mali Amirault, Thomas W Flaig, Elaine T Lam
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer research communications 3 (6) (2023)
Brett Wiesen, Michael Atwell, Colton Leavitt, Nathan Clark, Elizabeth R Kessler, Elaine T Lam, Thomas W Flaig, Janet Kukreja, Simon P Kim, Paul Maroni, Nicholas G Cost
Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer. JCO oncology practice 20 (3) (2023)
Brett Wiesen, Michael Atwell, Colton Leavitt, Nathan Clark, Elizabeth R Kessler, Elaine T Lam, Thomas W Flaig, Janet Kukreja, Simon P Kim, Paul Maroni, Nicholas G Cost
Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer. JCO oncology practice (2023)
Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin J Eule, Geetika Srivastava, Douglas J Kemme, Praveena Iruku, Vishal Rana, James Moore, Steven R Schuster, Mali Amirault, Thomas W Flaig, Elaine T Lam
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer research communications 3 (6) (2023)
Brett Wiesen, Michael Atwell, Colton Leavitt, Nathan Clark, Elizabeth R Kessler, Elaine T Lam, Thomas W Flaig, Janet Kukreja, Simon P Kim, Paul Maroni, Nicholas G Cost
Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer. JCO oncology practice 20 (3) (2023)
Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin J Eule, Geetika Srivastava, Douglas J Kemme, Praveena Iruku, Vishal Rana, James Moore, Steven R Schuster, Mali Amirault, Thomas W Flaig, Elaine T Lam
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer research communications 3 (6) (2023)
Corbin J Eule, Thomas W Flaig, Katy Wong, Ryon P Graf, Elaine T Lam
Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations. Prostate cancer and prostatic diseases (2022)
Daniel B Green, Francisco G La Rosa, Paul G Craig, Francesca Khani, Elaine T Lam
Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors. Korean journal of radiology 22 (10) (2021)
Shahzaib Nabi, Elizabeth R Kessler, Brandon Bernard, Thomas W Flaig, Elaine T Lam
Renal cell carcinoma: a review of biology and pathophysiology. F1000Research 7 (2018)